Hospira Gemcitabine Injection (38 mg/mL) 1 g/26.3 mL (US)

Země: Austrálie

Jazyk: angličtina

Zdroj: Department of Health (Therapeutic Goods Administration)

Aktivní složka:

gemcitabine hydrochloride, Quantity: 43.27 mg/mL

Dostupné s:

Hospira Australia Pty Ltd

INN (Mezinárodní Name):

Gemcitabine hydrochloride

Léková forma:

Injection, solution

Složení:

Excipient Ingredients: sodium hydroxide; hydrochloric acid; water for injections

Podání:

Intravenous Infusion

Jednotky v balení:

1 x 26.3 mL pack

Třída:

Medicine Listed (Export Only)

Druh předpisu:

(S1) This Schedule is intentionally blank

Terapeutické indikace:

Ovarian cancer, breast cancer, non small cell lung cancer, pancreatic cancer

Přehled produktů:

Visual Identification: A clear, colourless or light straw coloured solution practically free from visible particulates; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 18 Months; Container Temperature: Store at 2 to 8 degrees Celsius; Container Closure: Child resistant closure and restricted flow insert

Stav Autorizace:

Licence status A

Datum autorizace:

2011-11-04